Voriconazole Pharmacokinetics and Safety in Immunocompromised Children Compared to Adult Patients

The aim of this study was to investigate the pharmacokinetics and safety of voriconazole after intravenous (i.v.) administration in immunocompromised children (2 to 11 years old) and adults (20 to 60 years old) who required treatment for the prevention or therapy of systemic fungal infections. Nine...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Michael, Claudia, Bierbach, Uta, Frenzel, Katrin, Lange, Thoralf, Basara, Nadezda, Niederwieser, Dietger, Mauz-Körholz, Christine, Preiss, Rainer
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology (ASM) 2010
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2916341/
https://ncbi.nlm.nih.gov/pubmed/20547816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01731-09
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak